Researchers are developing compounds that simulate the benefits of physical exercise, potentially offering new treatments for muscle atrophy, heart failure, and neurodegenerative diseases. The compound SLU-PP-332 and its derivatives activate key proteins involved in exercise-induced muscle growth and metabolism.